Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Long-Term Deferred Tax (2011 - 2026)

Iqvia Holdings' (IQV) quarterly Long-Term Deferred Tax came in at $421.0 million in Q2 2026, up 22.03% year-over-year from $345.0 million in Q2 2025, and up 17.6% quarter-over-quarter from $358.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Long-Term Deferred Tax across 16 years of filings, most recently posting $421.0 million for Q2 2026.

  • In Q2 2026, Long-Term Deferred Tax rose 22.03% year-over-year to $421.0 million; the TTM figure through Jun 2026 stood at $421.0 million (up 22.03% YoY), while the FY2025 annual figure was $357.0 million, up 84.02% from the prior year.
  • Long-Term Deferred Tax came in at $421.0 million for Q2 2026 at Iqvia Holdings, up from $358.0 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $421.0 million in Q2 2026 to a low of $97.0 million in Q3 2022.
  • Average Long-Term Deferred Tax over 5 years is $208.7 million, with a median of $161.0 million recorded in 2024.
  • Year-over-year, Long-Term Deferred Tax declined 7.62% in 2022 and surged 137.8% in 2025.
  • Over 5 years, Long-Term Deferred Tax stood at $118.0 million in 2022, then jumped by 40.68% to $166.0 million in 2023, then climbed by 16.87% to $194.0 million in 2024, then surged by 84.02% to $357.0 million in 2025, then rose by 17.93% to $421.0 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $421.0 million in Q2 2026, $358.0 million in Q1 2026, and $357.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 421.00 Mn
Mar 31, 2026 358.00 Mn
Dec 31, 2025 357.00 Mn
Sep 30, 2025 390.00 Mn
Jun 30, 2025 345.00 Mn
Mar 31, 2025 245.00 Mn
Dec 31, 2024 194.00 Mn
Sep 30, 2024 164.00 Mn
Jun 30, 2024 158.00 Mn
Mar 31, 2024 152.00 Mn
Dec 31, 2023 166.00 Mn
Sep 30, 2023 111.00 Mn
Jun 30, 2023 115.00 Mn
Mar 31, 2023 125.00 Mn
Dec 31, 2022 118.00 Mn
Sep 30, 2022 97.00 Mn
Jun 30, 2022 120.00 Mn
Mar 31, 2022 120.00 Mn
Dec 31, 2021 124.00 Mn
Sep 30, 2021 105.00 Mn